These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 19691112)

  • 41. ALK-positive anaplastic large cell lymphoma with dic(2;4)(p23;q33).
    Niitsu N; Kohri M; Hayama M; Tamaru J; Miura I
    Leuk Res; 2009 Jun; 33(6):e23-5. PubMed ID: 19036440
    [No Abstract]   [Full Text] [Related]  

  • 42. [Nuclear microarray combined with fluorescence in situ hybridization for detecting ALK gene translocation in paraffin-embedded anaplastic large cell lymphoma and its significance].
    Li HL; Jiang HY; Ji TH; Chu HJ; Liu F; Chen XY; Wang X; Zhang G; Zhao T
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Apr; 28(4):572-5. PubMed ID: 18495593
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Array-CGH analysis of cutaneous anaplastic large cell lymphoma.
    Szuhai K; van Doorn R; Tensen CP; Van Kester
    Methods Mol Biol; 2013; 973():197-212. PubMed ID: 23412792
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pediatric inflammatory myofibroblastic tumor: anaplastic lymphoma kinase (ALK) expression and prognosis.
    Chun YS; Wang L; Nascimento AG; Moir CR; Rodeberg DA
    Pediatr Blood Cancer; 2005 Nov; 45(6):796-801. PubMed ID: 15602716
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of ALK germline mutation (3605delG) in pediatric anaplastic medulloblastoma.
    Coco S; De Mariano M; Valdora F; Servidei T; Ridola V; Andolfo I; Oberthuer A; Tonini GP; Longo L
    J Hum Genet; 2012 Oct; 57(10):682-4. PubMed ID: 22810114
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Oncogenic anaplastic lymphoma kinase (ALK) mutation in neuroblastomas and other pediatric tumors.
    Kwon MJ; Choi YL; Sung KW; Kang SY; Park SM; Choi SY; Kim JS; Suh YL
    Pathol Res Pract; 2011 Oct; 207(10):634-9. PubMed ID: 21940108
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Kinetics of humoral response to ALK and its relationship with minimal residual disease in pediatric ALCL.
    Mussolin L; Bonvini P; Ait-Tahar K; Pillon M; Tridello G; Buffardi S; Lombardi A; Pulford K; Rosolen A
    Leukemia; 2009 Feb; 23(2):400-2. PubMed ID: 18615104
    [No Abstract]   [Full Text] [Related]  

  • 48. Education and Imaging: Gastrointestinal: gastroduodenal involvement of ALK-positive anaplastic large cell lymphoma.
    Ishii H; Isomoto H; Taniguchi H; Kinoshita N; Matsushima K; Taguchi J; Miyazaki Y; Nakao K
    J Gastroenterol Hepatol; 2011 May; 26(5):933. PubMed ID: 21488949
    [No Abstract]   [Full Text] [Related]  

  • 49. Minimal Residual Disease Monitoring Using a 3'ALK Universal Probe Assay in ALK-Positive Anaplastic Large-Cell Lymphoma: ddPCR, an Attractive Alternative Method to Real-Time Quantitative PCR.
    Quelen C; Grand D; Sarot E; Brugières L; Sibon D; Pradines A; Laurent C; Brousset P; Lamant L
    J Mol Diagn; 2021 Feb; 23(2):131-139. PubMed ID: 33246076
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Progress in diagnosis and treatment of ALK positive anaplastic large cell lymphoma].
    Tang XW; Wu DP
    Zhonghua Xue Ye Xue Za Zhi; 2011 Mar; 32(3):208-11. PubMed ID: 21535966
    [No Abstract]   [Full Text] [Related]  

  • 51. Genomic imbalances in Hodgkin lymphoma.
    Küppers R
    Blood; 2010 Jul; 116(3):309-11. PubMed ID: 20651079
    [No Abstract]   [Full Text] [Related]  

  • 52. No small matter: qualitatively distinct challenges of pediatric genomic studies.
    Kohane IS
    Genome Med; 2011 Sep; 3(9):62. PubMed ID: 21961648
    [No Abstract]   [Full Text] [Related]  

  • 53. Updates in pathobiological aspects of anaplastic large cell lymphoma.
    Wu R; Lim MS
    Front Oncol; 2023; 13():1241532. PubMed ID: 37810974
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Patient-derived xenograft models of ALK+ ALCL reveal preclinical promise for therapy with brigatinib.
    Prokoph N; Matthews JD; Trigg RM; Montes-Mojarro IA; Burke GAA; Fend F; Merkel O; Kenner L; Geoerger B; Johnston R; Murray MJ; Riguad C; Brugières L; Turner SD
    Br J Haematol; 2023 Sep; 202(5):985-994. PubMed ID: 37357529
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Notch Signaling Promotes Mature T-Cell Lymphomagenesis.
    Gao X; Wang C; Abdelrahman S; Kady N; Murga-Zamalloa C; Gann P; Sverdlov M; Wolfe A; Polk A; Brown N; Bailey NG; Inamdar K; Casavilca-Zambrano S; Montes J; Barrionuevo C; Taxa L; Reneau J; Siebel CW; Maillard I; Wilcox RA
    Cancer Res; 2022 Oct; 82(20):3763-3773. PubMed ID: 36006995
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genetic profiling and biomarkers in peripheral T-cell lymphomas: current role in the diagnostic work-up.
    Vega F; Amador C; Chadburn A; Hsi ED; Slack G; Medeiros LJ; Feldman AL
    Mod Pathol; 2022 Mar; 35(3):306-318. PubMed ID: 34584212
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Whole Exome Sequencing reveals NOTCH1 mutations in anaplastic large cell lymphoma and points to Notch both as a key pathway and a potential therapeutic target.
    Larose H; Prokoph N; Matthews JD; Schlederer M; Högler S; Alsulami AF; Ducray SP; Nuglozeh E; Fazaludeen FMS; Elmouna A; Ceccon M; Mologni L; Gambacorti-Passerini C; Hoefler G; Lobello C; Pospisilova S; Janikova A; Woessmann W; Damm-Welk C; Zimmermann M; Federova A; Malone A; Smith O; Wasik M; Inghirami G; Lamant L; Blundell TL; Klapper W; Merkel O; Burke AGA; Mian S; Ashankyty I; Kenner L; Turner SD
    Haematologica; 2021 Jun; 106(6):1693-1704. PubMed ID: 32327503
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Burkitt-Type Acute Lymphoblastic Leukemia With Precursor B-Cell Immunophenotype and Partial Tetrasomy of 1q: A Case Report.
    Sato Y; Kurosawa H; Fukushima K; Okuya M; Arisaka O
    Medicine (Baltimore); 2016 Mar; 95(10):e2904. PubMed ID: 26962787
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Genetic alterations in systemic nodal and extranodal non-cutaneous lymphomas derived from mature T cells and natural killer cells.
    Boi M; Stathis A; Zucca E; Inghirami G; Bertoni F
    Cancer Sci; 2012 Aug; 103(8):1397-404. PubMed ID: 22568409
    [TBL] [Abstract][Full Text] [Related]  

  • 60. New developments in the pathology of malignant lymphoma: a review of the literature published from August to November 2009.
    van Krieken JH
    J Hematop; 2009 Dec; 2(4):245-51. PubMed ID: 20309432
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.